Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 23

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 neutralizing ELISA antibodies protein epitopes sars-cov patients TGEV scfv DENV HIV-1 mers-cov bovine PEDV igy
2 antibodies detection human expressed epitope SARS igg feline library dengue ZIKV influenza rotavirus diarrhea VWF
3 infection assay production recombinant peptides acute days FIPV phage heavy broadly HA immunoglobulins porcine yolk
4 mabs test generation expression linear acute respiratory syndrome 229E gastroenteritis scfvs ig bnabs H5N1 species epidemic B.
5 activity sensitivity monoclonal antibodies coli peptide severe OC43 transmissible clones light b12 east S/N piglets serovars
6 domain % monoclonal purified mabs respiratory onset transmissible gastroenteritis virus display chain gp120 middle typhimurium epidemic diarrhea virus s-protein
7 mab samples technology gene amino syndrome iga strain fab chains design H1N1 BP LACA orientalis
8 RBD immunosorbent pathogens fusion antigenic n protein serum cats panning genes X5 VEEV calves pedv s protein sev
9 neutralizing antibodies serum diseases vector mapping protein day virus variable tc germline RVFV salmonella HPV proteins
10 neutralization enzyme-linked cell E. protein coronavirus igm MHV phages repertoires V3 middle east respiratory syndrome coronavirus ICA cystatin egg
11 binding positive antigens western immunodominant nucleocapsid HCV VN papn 69 germline-like RVF igys CV777 gondii
12 virus sera applications cloned b-cell sars-cov. titers FIP EBOV peripheral envelope celisa ETEC n-protein leptospiral
13 sars-cov-2 developed screening chromatography recognized patients titer BCV fragments mononuclear pseudoviruses MERS HBV swine leptospiral serovars
14 neutralizing activity detect methods escherichia located spike samples peritonitis single-chain immunoglobulin HIV subtype ige SUPPLEMENTARY GICA
15 receptor serological immune e. coli region cov antibody strains binding IGHV1 anti-v3 LASV anti-idiotypic G2 T.
16 glycoprotein specificity method fusion protein residues NP serum samples antigenic sequence analysis peripheral blood mononuclear cells immunogens SFTSV conjugate EMCV parasite
17 2 antigen antigen escherichia coli identified sars-cov infection avidity virulent biopanning somatic vaccine H5 S. online egg yolk
18 protection negative antibody amplified JEV convalescent % mouse sdabs usage elicitation SFTS colloidal pdcov fibrillae
19 monoclonal detecting strategy blotting acids spike protein seroconversion inoculated rounds autoantibodies env MN CSF authorized ADAMTS13
20 effective sensitive cells blot motif acute respiratory syndrome coronavirus group swine scfv antibodies serotype germline antibodies H7N9 hbsag users CFT
21 GP enzyme-linked immunosorbent assay describe DNA linear epitopes sars‐cov times NT phage-displayed b cells evolution hemagglutinin peroxidase pigs fanc
22 bind elisas display balb/c mice conformational sars-associated coronavirus illness macrophages VHH VH elicit mers-cov. SCP fecal western blots
23 treatment serum samples efficient plasmid IBV nucleocapsid protein iggs porcine SEB dengue virus divergent viruses K99 supplementary western
24 - tcov generate balb/c site E6 CF differences PA germline hiv-1 vaccine pandemic anti-idiotypic antibodies ascitic fluid kda
25 escape turkey targets western blotting minimal S450 children peplomer immobilized transgenic mice gp41 live osteoclast BV hybrid
26 entry commercial including encoding conformational epitopes sars coronavirus WU TGE × blood envs vesicular hyenas G1 signals
27 antibody based recombinant antibodies expression vector overlapping sera groups MHV-4 lymphocytes serotypes structure H3N2 s. typhimurium PED APP
28 viral indirect review mice NS1 N1 positive 2–4 affinity variable structures 2009 hyena anti-pedv VSA(PAM
29 hmabs compared surface tag conserved 650 levels isolates constructed trials hypothesis ha protein rabies spleen cells spp
30 neutralize capture molecules baculovirus amino acids hcov-oc43 sera PRRSV binders carrying gdes horse plant version FAH
31 neutralizing antibody results approach + acid sars-cov-infected adults homologous avium tc cattle B2.1 hvs bats myeloma ducks
32 interaction WB isolation prokaryotic antigenic structure S2 ssc attenuated vhhs hcabs responses lasv-rnp 1:2 rgst-s1d hens
33 human tested cloning western blot strains anti-n measured prepared random DIII broad CHIKV spotted rgst-coe IFAT
34 ACE2 ccov limitations cells reactivity sars-coronavirus onset of 43 selected DENV-2 computational stem RIG meat juice burgdorferi
35 epitopes nucleocapsid libraries proteins linear epitope S450–650 F1 CCV chain regions V1/V2 JUNV M/VP-2 MATERIAL secondary
36 showed values development length terminal patient sera collected distinguished peptide human pathways containment pteropus phe-cov ab
37 receptor-binding kit exposure insect epitope-based N3 density 79 V(NAR light chains hypothesized fever FCS ELECTRONIC horses
38 lethal protein-based technologies HMPV c-terminus pneumonia median electron VP35 HAC hiv-1 infection 8C6 HRPO nmabs avian
39 epitope dogs platform analysis covering 2C5 detected infectious peritonitis equilibrium gdna engineer H7 extracts s-based t. gondii
40 potency PRRS viral polymerase study proteins iga antibodies TO-163 ligands clinical trials gpi-anchored h5n1 viruses MBP gd gonorrhoeae
41 ADE antibodies polyclonal IPTG ns1 protein fragment IAHA cells subsp heavy- tier H1 fanc protein genotype PAM
42 protected antibody intracellular BL21 diagnostic assays syndrome-associated VP2 coronaviruses sequence light-chain 7B3 GTV RANK pig b. burgdorferi
43 protein agreement engineering showed monoclonal N2 response reacted phage-elisa loci question humans isotype-specific spike protein CS31A
44 ebola recombinant amounts multiepitope mab recombinant nucleocapsid protein rhinovirus BP03-P peripheral lymphocytes plasma zika virus mcas mice caballi
45 variants igg protocol insect cells monoclonal antibodies anti-s disease mouse hepatitis virus SA59B single mature neutralization anti-hbs result secondary antibodies
46 mechanism IDEXX HCMV ni suis hcov haemagglutination radioimmunoassay hcd13 higgs hiv-1 envelope glycoprotein inactivated formalin-inactivated balb/c igy antibodies
47 spike virus discovery molecular mass WNV recombinant IHA PRCV paratuberculosis heavy chain hiv-1 envelope respiratory ICS virus CVA16
48 inhibit quantitative infectious diseases DE3 differential - pediatric immunofluorescence dissociation cassettes zika virus animal specific g2b secondary antibody
49 vaccine elisa-rn milk recombinant plasmid linear b-cell epitope N195 virol coronavirus vhh antibodies hpabs affinity OD iga pan-hpv immunodiagnostics
50 receptor-binding domain performance desired rerp mimotopes 2003 seroepidemiological titers pt-gliadin DENV2 plasma nebulization enzyme F(19)VAQPVY(25 infected